Induction of Mitochondrial-Mediated Apoptosis by Morinda Citrifolia (Noni) in Human Cervical Cancer Cells

Department of Biochemistry, All India Institute of Medical Science, Ansari Nagar, New Delhi, India E-mail : .
Asian Pacific journal of cancer prevention: APJCP (Impact Factor: 1.5). 01/2013; 14(1):237-242. DOI: 10.7314/APJCP.2013.14.1.237
Source: PubMed

ABSTRACT Cervical cancer is the second most common cause of cancer in women and has a high mortality rate. Cisplatin, an antitumor agent, is generally used for its treatment. However, the administration of cisplatin is associated with side effects and intrinsic resistance. Morinda citrifolia (Noni), a natural plant product, has been shown to have anti-cancer properties. In this study, we used Noni, cisplatin, and the two in combination to study their cytotoxic and apoptosis-inducing effects in cervical cancer HeLa and SiHa cell lines. We demonstrate here, that Noni/Cisplatin by themselves and their combination were able to induce apoptosis in both these cell lines. Cisplatin showed slightly higher cell killing as compared to Noni and their combination showed additive effects. The observed apoptosis appeared to be mediated particularly through the up-regulation of p53 and pro-apoptotic Bax proteins, as well as down- regulation of the anti-apoptotic Bcl-2, Bcl-XL proteins and survivin. Augmentation in the activity of caspase-9 and -3 was also observed, suggesting the involvement of the intrinsic mitochondrial pathway of apoptosis for both Noni and Cisplatin in HeLa and SiHa cell lines.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The miracle medicinal plant Morinda citrifolia L., also called as Noni, Great Morinda or Indian mulberry, belongs to the family Rubiaceae. Its fruit has been used traditionally for more than 2000 years by native Polynesians. However, all parts of the plant have medicinal properties. More than 160 phytochemicals have been isolated from the plant Noni, which makes it an amazing herbal remedy for the treatment of numerous disorders including cancer. Recently, the Noni juice has been in high demand in market as complementary and alternative medicine (CAM) for its multi-dimensional health benefits. It is a potent antibacterial, antiviral, antifungal, antihelminthic, anticancer, analgesic, anti-inflammatory, anti-oxidant, hypotensive, cardiovascular protective, wound healer, anxiolytic, sedative, antigout, antiobesity and immune enhancing agent. Anticancerous activity of Morinda citrifolia is attributable to its anti-inflammatory, antioxidant and apoptosis-inducing effects. Based on toxicological and mutagenicity assessment, Noni juice has been considered as safe. Few reports of hepatotoxicity exist, although there are many evidences suggesting hepatoprotective effects of Noni. Even though large number of in vitro studies has been carried out but only few clinical trials exist in the literature to suggest real beneficial effects of Noni in humans. Recently, Noni fruit juice has been accepted as a novel food element in the European Union. A number of scientific studies have been conducted to elucidate the mechanism of action of phytoconstituents of Noni. In this review, active phytochemical constituents, pharmacological properties, mechanism of action, and various immunomodulatory and therapeutic potentials of Noni usage as a useful herbal medicine are discussed in detail, which could be very helpful in safeguarding health of humans and their companion animals. A special focus has been made on the potent utility of this wonderful herbal plant in preventing and treating the deadly malady of cancer.
    International Journal of Pharmacology 05/2014; 9(8):462-492.. DOI:10.3923/ijp.2013.462.492 · 0.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Realgar which contains arsenic components has been used in traditional Chinese medicine (TCM) as an anticancer drug. However, neither Realgar nor its formula are soluble in water. As a result, high dose of Realgar has to be administered to achieve an effective blood medicine concentration, and this is associated with adverse side effects. The objective of the present study was to increase the solubility of a formula using hydrometallurgy technology as well as investigating its effects on in vitro and in vivo cell proliferation and apoptosis in Sarcoma-180 cell line. Materials and Methods: Antiproliferative activity of Realgar Bioleaching Solution (RBS) was evaluated by MTT assay. Further, effects of RBS on cell proliferation and apoptosis were studied using flow cytometry and transmission electron microscopy. Kunming mice were administered RBS in vivo, where arsenic specifically targeted solid tumors. Results: The results indicated that RBS extract potently inhibited the tumor growth of Sarcoma-180 cell line in a dose-dependent manner. Flow cytometry and transmission electron microscopy further indicated that RBS significantly induced cell apoptosis through the inhibition of cell cycle pathway in a dose-dependent manner. Further, on RBS administration to mice, arsenic was specifically targeted to solid tumor.s Conclusions: RBS could substitute for traditional Realgar or its formula to work as a potent tool in cancer treatment.
    Asian Pacific journal of cancer prevention: APJCP 03/2014; 15(6):2883-8. DOI:10.7314/APJCP.2014.15.6.2883 · 1.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To investigate the effects of abnormal Savda Munziq (ASMq) total phenolics combined with cisplatin and docetaxel on the Hela cell growth. Methods: In vivo cultured Hela cells were treated with cisplatin, docetaxel, total phenolics, cisplatin+total phenolics or docetaxel+total phenolics. MTT was performed to assess inhibition of cell proliferation, flow cytometry to detect apoptosis, and semi-quantitative RT-PCR to test for survivin and Bcl-2 expression. Results: The total phenolics, cisplatin and docetaxel had significant inhibitory and apoptosis-promoting effects on Hela cells (P<0.05), with the early apoptotic rates of 12.8±0.70%, 18.9±3.79% and 15.8±3.8)%; the total phenolics, cisplatin and docetaxel significantly decreased the expression of Bcl-2 and survivin (all P<0.01), especially when used in combination. Conclusion: ASMq total phenolics, combined with cisplatin and docetaxel, could promote the apoptosis of Hela cells possibly through reducing the expression of Bcl-2 and survivin.
    Asian Pacific journal of cancer prevention: APJCP 01/2014; 15(2):743-7. DOI:10.7314/APJCP.2014.15.2.743 · 1.50 Impact Factor


Available from

Similar Publications